Worldwide delivery with DHL in 7–21 days10 vials a packOver $499: free shipping + bac water giftPay with Revolut, PayPal or cardAffiliates: up to 12% →Research use onlyMy account
BP BioLabsClinical catalogShop
Black Week−10% on everythingapplied automatically at checkoutuntil 27 NovemberShop now →

Our most searched product

Buy CBL-514

CBL-514 is an investigational small molecule studied for localised fat reduction. We stock it in four dosages, each as a pack of 10 vials, for in vitro laboratory research only.

CBL-514 · BP BioLabs

Dosages and prices

DosagePack of 10 vialsPer vialPer mg
10 mg$356.20 $320.58$32.06$3.20
20 mg$593.80 $534.42$53.44$2.67
50 mg$1,187.60 $1,068.84$106.88$2.14
100 mg$2,375.00 $2,137.50$213.75$2.14

At a glance

  • Purity specification ≥99% on every batch
  • Pack of 10 vials: the smallest order
  • DHL worldwide, usually in 7–21 days, $50 per order
  • Card, Apple Pay or Google Pay on a secure payment page
  • Discreet, unbranded parcel with tracking
  • In vitro laboratory research only, buyers 21+

What CBL-514 is

CBL-514 is an investigational compound developed by Caliway Biopharmaceuticals in Taiwan. The trial reports describe it as a small molecule, not a peptide, that acts on fat tissue where it is given and makes fat cells undergo apoptosis, a form of programmed cell death.

Where the research stands

CBL-514 is not an approved medicine in any country. Two phase 3 trials are registered on ClinicalTrials.gov: one began recruiting in September 2026, and SUPREME-02, planned for 320 participants, was not yet recruiting at the start of November 2026.

The full guide, with sources: CBL-514: what the research shows →

News and research timeline

  1. Nov 2026

    SUPREME-02, a second phase 3 trial planned for 320 participants, is registered on ClinicalTrials.gov; at the start of November it was not yet recruiting. Source ↗

  2. Sep 2026

    The first phase 3 trial of CBL-514 for reducing fat under the skin began recruiting. Source ↗

  3. Jul 2026

    A phase 3b extension study is registered: about 300 people who completed the two phase 3 trials, followed for long-term safety and how long the effect lasts. Planned start: December 2026. Source ↗

  4. Jun 2026

    A phase 2b trial with repeated long-term treatment, planned for about 250 participants, began recruiting. Source ↗

  5. 2026

    Phase 2b results published (Aesthetic Surgery Journal): at 12 weeks, 76.7% of participants on CBL-514 improved by at least one grade on a clinician-rated abdominal fat scale, against 18.9% on placebo. Source ↗

  6. 2026

    A randomised phase 2a study in Dercum's disease lipomas (painful fatty lumps) was published in JAAD International. Source ↗

  7. 2025

    Phase 2 results published (Aesthetic Surgery Journal): eight weeks after the last treatment, 69.6% of participants on CBL-514 had lost at least 150 ml of abdominal fat volume, against none on placebo. Source ↗

Summaries of registered trials and published research, for reference only: not a promise of any effect.

Questions about CBL-514

How much does CBL-514 cost?

A pack of 10 vials costs from $320.58 (10 mg) to $2,137.50 (100 mg). Per mg it starts at $2.14. Shipping is $50 per order.

Which dosages do you sell?

10 mg, 20 mg, 50 mg & 100 mg per vial, always as a pack of 10 vials.

Who develops CBL-514?

CBL-514 is developed by Caliway Biopharmaceuticals, a company based in Taiwan, which also sponsors its clinical trials. We are an independent supplier with no connection to Caliway: we sell the compound as a reagent for in vitro laboratory research, not the investigational medicine used in those trials.

Is CBL-514 a code name?

Yes. CBL-514 is the development code of the compound. It has no brand name yet, because it is still in clinical trials and is not an approved medicine in any country.

How is CBL-514 shipped?

With DHL, worldwide, usually in 7–21 days, in a discreet unbranded parcel with tracking.

Do you ship to Germany, Austria and Switzerland?

Yes, with DHL and tracking, usually in 7–21 days. Germany and Austria are in the EU: import VAT or duties, if any, are charged on delivery, as for any parcel from outside the EU; Switzerland applies its own import rules.

How can I pay?

By card, Apple Pay or Google Pay on a secure payment page; depending on your country also PayPal or bank transfer.

What does the code name CBL-514 stand for?

CBL-514 is the development code under which Caliway Biopharmaceuticals of Taiwan runs the compound in its studies. A compound only gets a brand name once it is approved, and CBL-514 is not approved.

Is CBL-514 a peptide?

No. The published trial reports describe it as a small molecule, not a peptide.

Is CBL-514 approved?

No. It is an investigational compound: in November 2026 phase 3 trials are registered, and one of them is recruiting.

What is CBL-514 being studied for?

Localised fat: abdominal fat under the skin, cellulite and the painful fatty lumps of Dercum's disease.

Can I buy CBL-514 for personal use?

No. Everything we sell is for in vitro laboratory research by adults aged 21 or over. It is not for use in people or animals, and we give no advice on use or dosing.

🔒 Anonymous packaging. We delete all your personal data as soon as your order ships.